Baxter voluntary recalls Potassium Chloride Injection due to labeling error

Baxter International is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826 distributed to the hospital/pharmacy/nurse level for the treatment of potassium deficiency. The affected lot of Potassium Chloride Injection was distributed to customers in the United States between May 26, 2014 and August 8, 2014.

The recall is being initiated due to a labeling error on the shipping cartons in a single lot, which was identified by three customers. Shipping cartons labeled for this specific lot number of Potassium Chloride Injection may contain units of Gentamicin Sulfate Injection, an antibacterial drug, 80 mg in 100 mL, product code 2B0862. Potassium Chloride is indicated for treatment of potassium deficiency and administered intravenously. Gentamicin Sulfate is an antibacterial drug for intravenous administration. As both products are packaged in 100 mL containers, have similar code numbers and red labeling on the front panel, there is a potential risk of medication error or delay in therapy for patients that require high-concentration potassium chloride.

In March, the company recalled a single lot of a peritoneal product used by dialysis patients which had been contaminated with mold. In July, the company initiated a worldwide recall of three lots of sodium chloride as well as one of highly concentrated potassium chloride.